Keywords: setback, medeva, fda, seeks, data, hepagene, shares

Setback for Medeva as FDA seeks more data on Hepagene

Article | 13 April 1999

Print This

Shares in the UK pharmaceutical company Medeva took a downturn after theUS Food and Drug Administration asked for more information ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in